Travere Therapeutics Inc
(TVTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2006 | |
| Sales | 28,203 | 0 | 0 | 0 | 0 |
| Cost of Goods | 571 | 0 | N/A | 3,137 | N/A |
| Gross Profit | 27,632 | N/A | N/A | -3,137 | N/A |
| Operating Expenses | 108,011 | 24,773 | 30,257 | 264 | 0 |
| Operating Income | -79,808 | -24,773 | -30,257 | -3,264 | N/A |
| Interest Expense | 12,156 | 46 | 84 | 0 | 0 |
| Other Income | -21,434 | -9,730 | -3 | -5 | 0 |
| Pre-tax Income | -113,398 | -34,549 | -30,344 | -3,268 | 0 |
| Income Tax | -2,460 | 76 | N/A | N/A | N/A |
| Net Income Continuous | -110,938 | -34,625 | -30,344 | -3,268 | N/A |
| Net Income | $-110,938 | $-34,625 | $-30,344 | $-3,268 | $N/A |
| EPS Basic Total Ops | -4.43 | -2.44 | -8.29 | -1.59 | N/A |
| EPS Basic Continuous Ops | -4.43 | -2.44 | -8.29 | -1.59 | N/A |
| EPS Diluted Total Ops | -4.43 | -2.44 | -8.29 | -1.59 | N/A |
| EPS Diluted Continuous Ops | -4.43 | -2.44 | -8.29 | -1.59 | N/A |
| EBITDA(a) | $-73,323 | $-24,557 | $-30,132 | $-3,263 | $N/A |